
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 4, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 4, 2024
Язык: Английский
BMC Cancer, Год журнала: 2025, Номер 25(1)
Опубликована: Фев. 11, 2025
Tendomodulin (TNMD) is pivotal in various malignancies, including colorectal cancer (CRC). However, its comprehensive impact across cancers, particularly immunomodulatory function CRC, remains underexplored. This study explored the role of TNMD CRC by focusing on functions through molecular and clinical analyses. Multiple bioinformatics databases analytical tools were utilized for pan-cancer analysis. To validate we performed experiments, immunofluorescence (IF), immunohistochemistry (IHC), real-time quantitative reverse transcription PCR (qPCR), western blotting, cell migration assays. expression gene mutation vary cancers offer high diagnostic value. Survival analysis found that associated with prognosis multiple cancers. Notably, patients microsatellite instability (MSI-H) correlated positively immune cells, natural killer (NK) whereas it was inversely regulatory T cells (Tregs). Crucially, stability (MSS) better immunotherapy outcomes, indicating potential as a biomarker patient stratification tailored treatment approaches. Furthermore, single-cell sequencing data revealed stronger interactions between TNMD-positive tumor fibroblasts or macrophages microenvironment. Finally, overexpressed tissues lines, thereby promoting invasion metastasis. Our findings reveal critical influencing tumor–immune interactions. Beyond prognostic biomarker, promotes metastasis invasion, thus emerging promising therapeutic target. These highlight TNMD's significance potentially other malignancies.
Язык: Английский
Процитировано
0Medical Oncology, Год журнала: 2025, Номер 42(4)
Опубликована: Фев. 28, 2025
Язык: Английский
Процитировано
0Inorganic Chemistry, Год журнала: 2024, Номер 63(28), С. 12870 - 12879
Опубликована: Июнь 4, 2024
Drug resistance, one of the main drawbacks in cancer chemotherapy, can be tackled by employing a combination drugs that target different biological processes cell, enhancing therapeutic efficacy. Herein, we report synthesis and characterization new paddlewheel diruthenium complex includes 5-fluorouracil (5-FU), commonly used anticancer drug. This drug was functionalized with carboxylate group to take advantage previously demonstrated release capacity ligands from core. The resulting hydrophobic complex, [Ru2Cl(DPhF)3(5-FUA)] (Ru-5-FUA) (DPhF = N,N′-diphenylformamidinate; 5-FUA 5-fluorouracil-1-acetate) subsequently entrapped poly(methyl methacrylate) (PMMA) nanoparticles (PMMA@Ru-5-FUA) via reprecipitation method transported media. optimized encapsulation procedure yielded particles an average size 81.2 nm, PDI 0.11, zeta potential 29.2 mV. cytotoxicity tested vitro using human colon carcinoma cell line Caco-2. IC50 (half maximal inhibitory concentration) PMMA@Ru-5-FUA (6.08 μM) just slightly lower than found for 5-FU (7.64 μM). Most importantly, while cells seemed have developed resistance against 5-FU, showed almost complete lethality at ∼30 μM. Conversely, analogous devoid moiety, [Ru2Cl(DPhF)3(O2CCH3)] (PMMA@RuA), displayed reduced equivalent concentrations. These findings highlight effect combining properties those species. suggests distinct modes action two chemical species are crucial overcoming resistance.
Язык: Английский
Процитировано
3Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Ноя. 4, 2024
Язык: Английский
Процитировано
0